Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Graft vs Host Disease × 90 days × Clear all

Phase

Status

Recruiting 8 Active not recruiting 4 Not yet recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 193 Neoplasms 147 Prostatic Neoplasms 84 Colorectal Neoplasms 82 Carcinoma, Non-Small-Cell Lung 69 Melanoma 51 Lung Neoplasms 42 Head and Neck Neoplasms 41 Neoplasm Metastasis 38 Ovarian Neoplasms 35 Multiple Myeloma 35 Squamous Cell Carcinoma of Head and Neck 34 Pancreatic Neoplasms 34 Carcinoma, Hepatocellular 33 Colonic Neoplasms 32 Leukemia, Myeloid, Acute 30 Lymphoma 29 Brain Neoplasms 29 Recurrence 26 Urinary Bladder Neoplasms 24 Uterine Cervical Neoplasms 23 Parkinson Disease 4, Autosomal Dominant Lewy Body 23 Stomach Neoplasms 22 Gastrointestinal Neoplasms 22 Hematologic Neoplasms 21 Glioma 21 Rectal Neoplasms 20 Leukemia 20 Glioblastoma 20 Esophageal Neoplasms 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01520623 2026-03-05

Complement and Graft-versus-host Disease

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡